| Group A | Group B | P value |
Time (minutes)a1 | 48.5 (±12.0) | 31.9 (±5.6) | <0.001 |
HB/In (mL)a2 | 5700 (2000 - 9000) | 3.500 (1.250 - 12.000) | <0.01 |
HB/Retained (mL)b | 300 (0 - 3000) | 200 (0 - 600) | 0.23 |
Proliferative endometrium (SH)c | 12 (33.3) | 15 (40.5) | 0.05 |
Secretory endometrium (SH)c | 22 (61.1) | 17 (45.9) | 0.05 |
Uterine curettage (before SH)c | 10 (27.8) | 13 (35.1) | 0.05 |
Proliferative endometrium (AP)c | 10 (27.8) | 4 (10.8) | 0.05 |
Secretory endometrium (AP)c | 16 (44.4) | 10 (27) | 0.05 |
Atrophic endometrium (AP)c | 2 (5.6) | 3 (8.1) | 0.05 |
Polyp (AP)c | 14 (38.9) | 20 (54) | 0.05 |
Poly size in mm (AP)a1 | 18.75 (±11.57) | 18.07 (±9.86) | 0.88 |
Fibroid (AP)c | 4 (11.1) | 9 (24.3) | 0.05 |
Fibroid size in cm (AP)a1 | 3.33 (±2) | 3.42 (±1.39) | 0.93 |
Hyperplasia (AP)c | 5 (13.9) | 3 (8.1) | 0.05 |
Atypic hyperplasia (AP)c | 0 | 1 (2.7) | 0.05 |
Polyp hyperplasia (AP)c | 0 | 2 (5.4) | 0.05 |
Adenomyosis (AP)c | 0 | 3 (8.1) | 0.05 |
Urinary tract infection (UTI)c | 1 (2.8) | 2 (5.4) | 0.05 |
Vaginal dischargec | 11 (30.5) | 3 (8.1) | <0.05 |